 | • レポートコード：QYR2104Z0395 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、抗炎症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症生物製剤、非ステロイド性抗炎症薬（NSAID）、コルチコステロイド、その他）、用途別市場規模（関節炎、呼吸器疾患、皮膚科、消化器科、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・抗炎症治療の市場動向 ・企業の競争状況、市場シェア ・抗炎症治療の種類別市場規模（抗炎症生物製剤、非ステロイド性抗炎症薬（NSAID）、コルチコステロイド、その他） ・抗炎症治療の用途別市場規模（関節炎、呼吸器疾患、皮膚科、消化器科、その他） ・抗炎症治療の北米市場規模2016-2027（アメリカ、カナダ） ・抗炎症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗炎症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗炎症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗炎症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Johnson & Johnson、Amgen Inc、AstraZeneca PLC、Pfizer, Inc、Novartis、Roche、Merck、Sanofi、GlaxoSmithKline、Sun Pharmaceutical Industries Ltd、TEVA） ・結論 |
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
Market Analysis and Insights: Global Anti-inflammatory Therapeutics Market
The global Anti-inflammatory Therapeutics market size is projected to reach US$ 148620 million by 2026, from US$ 98030 million in 2019, at a CAGR of 6.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-inflammatory Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-inflammatory Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-inflammatory Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-inflammatory Therapeutics market.
Global Anti-inflammatory Therapeutics Scope and Market Size
Anti-inflammatory Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-inflammatory Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others
On the basis of product type, anti-inflammatory biologics segment is projected to account for the largest revenue share during the forecast period; this segment was estimated to account for 58.35% revenue share in 2019, at a cagr of 6.54% in the forecast period.
Segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Arthritis accounted for over 42.41% global revenue share in 2019. And it is also show a fast growth rate of 6.60% in the next few years from 2020 to 2026.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
AstraZeneca PLC
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-inflammatory Biologics
1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.2.4 Corticosteroids
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anti-inflammatory Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-inflammatory Therapeutics Market Perspective (2016-2027)
2.2 Anti-inflammatory Therapeutics Growth Trends by Regions
2.2.1 Anti-inflammatory Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-inflammatory Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Anti-inflammatory Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Anti-inflammatory Therapeutics Industry Dynamic
2.3.1 Anti-inflammatory Therapeutics Market Trends
2.3.2 Anti-inflammatory Therapeutics Market Drivers
2.3.3 Anti-inflammatory Therapeutics Market Challenges
2.3.4 Anti-inflammatory Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-inflammatory Therapeutics Players by Revenue
3.1.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-inflammatory Therapeutics Revenue
3.4 Global Anti-inflammatory Therapeutics Market Concentration Ratio
3.4.1 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapeutics Revenue in 2020
3.5 Anti-inflammatory Therapeutics Key Players Head office and Area Served
3.6 Key Players Anti-inflammatory Therapeutics Product Solution and Service
3.7 Date of Enter into Anti-inflammatory Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-inflammatory Therapeutics Breakdown Data by Type
4.1 Global Anti-inflammatory Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2022-2027)
5 Anti-inflammatory Therapeutics Breakdown Data by Application
5.1 Global Anti-inflammatory Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anti-inflammatory Therapeutics Market Size (2016-2027)
6.2 North America Anti-inflammatory Therapeutics Market Size by Type
6.2.1 North America Anti-inflammatory Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Anti-inflammatory Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Anti-inflammatory Therapeutics Market Size by Type (2016-2027)
6.3 North America Anti-inflammatory Therapeutics Market Size by Application
6.3.1 North America Anti-inflammatory Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Anti-inflammatory Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Anti-inflammatory Therapeutics Market Size by Application (2016-2027)
6.4 North America Anti-inflammatory Therapeutics Market Size by Country
6.4.1 North America Anti-inflammatory Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Anti-inflammatory Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Anti-inflammatory Therapeutics Market Size (2016-2027)
7.2 Europe Anti-inflammatory Therapeutics Market Size by Type
7.2.1 Europe Anti-inflammatory Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Anti-inflammatory Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Anti-inflammatory Therapeutics Market Size by Type (2016-2027)
7.3 Europe Anti-inflammatory Therapeutics Market Size by Application
7.3.1 Europe Anti-inflammatory Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Anti-inflammatory Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Anti-inflammatory Therapeutics Market Size by Application (2016-2027)
7.4 Europe Anti-inflammatory Therapeutics Market Size by Country
7.4.1 Europe Anti-inflammatory Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Anti-inflammatory Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type
8.2.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application
8.3.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region
8.4.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-inflammatory Therapeutics Market Size (2016-2027)
9.2 Latin America Anti-inflammatory Therapeutics Market Size by Type
9.2.1 Latin America Anti-inflammatory Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Anti-inflammatory Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Anti-inflammatory Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Anti-inflammatory Therapeutics Market Size by Application
9.3.1 Latin America Anti-inflammatory Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Anti-inflammatory Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Anti-inflammatory Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Anti-inflammatory Therapeutics Market Size by Country
9.4.1 Latin America Anti-inflammatory Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Anti-inflammatory Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type
10.2.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application
10.3.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country
10.4.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Anti-inflammatory Therapeutics Introduction
11.1.4 AbbVie Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Details
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Anti-inflammatory Therapeutics Introduction
11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.3.5 Amgen Inc Recent Development
11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Company Details
11.4.2 AstraZeneca PLC Business Overview
11.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Introduction
11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.4.5 AstraZeneca PLC Recent Development
11.5 Pfizer, Inc
11.5.1 Pfizer, Inc Company Details
11.5.2 Pfizer, Inc Business Overview
11.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Introduction
11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.5.5 Pfizer, Inc Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-inflammatory Therapeutics Introduction
11.6.4 Novartis Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Anti-inflammatory Therapeutics Introduction
11.7.4 Roche Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.7.5 Roche Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Anti-inflammatory Therapeutics Introduction
11.8.4 Merck Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Anti-inflammatory Therapeutics Introduction
11.9.4 Sanofi Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Introduction
11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.10.5 GlaxoSmithKline Recent Development
11.11 Sun Pharmaceutical Industries Ltd
11.11.1 Sun Pharmaceutical Industries Ltd Company Details
11.11.2 Sun Pharmaceutical Industries Ltd Business Overview
11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Introduction
11.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.11.5 Sun Pharmaceutical Industries Ltd Recent Development
11.12 TEVA
11.12.1 TEVA Company Details
11.12.2 TEVA Business Overview
11.12.3 TEVA Anti-inflammatory Therapeutics Introduction
11.12.4 TEVA Revenue in Anti-inflammatory Therapeutics Business (2016-2021)
11.12.5 TEVA Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-inflammatory Biologics
Table 3. Key Players of Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Table 4. Key Players of Corticosteroids
Table 5. Key Players of Others
Table 6. Global Anti-inflammatory Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Anti-inflammatory Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Anti-inflammatory Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Anti-inflammatory Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Anti-inflammatory Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Anti-inflammatory Therapeutics Market Share by Regions (2022-2027)
Table 12. Anti-inflammatory Therapeutics Market Trends
Table 13. Anti-inflammatory Therapeutics Market Drivers
Table 14. Anti-inflammatory Therapeutics Market Challenges
Table 15. Anti-inflammatory Therapeutics Market Restraints
Table 16. Global Anti-inflammatory Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Anti-inflammatory Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Anti-inflammatory Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Therapeutics as of 2020)
Table 19. Ranking of Global Top Anti-inflammatory Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Anti-inflammatory Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Anti-inflammatory Therapeutics Product Solution and Service
Table 23. Date of Enter into Anti-inflammatory Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-inflammatory Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Anti-inflammatory Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Anti-inflammatory Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Anti-inflammatory Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Anti-inflammatory Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Anti-inflammatory Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Anti-inflammatory Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Anti-inflammatory Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Anti-inflammatory Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Anti-inflammatory Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Anti-inflammatory Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Anti-inflammatory Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Anti-inflammatory Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Anti-inflammatory Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Anti-inflammatory Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Anti-inflammatory Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Anti-inflammatory Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Anti-inflammatory Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Anti-inflammatory Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Anti-inflammatory Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Anti-inflammatory Therapeutics Product
Table 66. AbbVie Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Anti-inflammatory Therapeutics Product
Table 71. Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Amgen Inc Company Details
Table 74. Amgen Inc Business Overview
Table 75. Amgen Inc Anti-inflammatory Therapeutics Product
Table 76. Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Amgen Inc Recent Development
Table 78. AstraZeneca PLC Company Details
Table 79. AstraZeneca PLC Business Overview
Table 80. AstraZeneca PLC Anti-inflammatory Therapeutics Product
Table 81. AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million)
Table 82. AstraZeneca PLC Recent Development
Table 83. Pfizer, Inc Company Details
Table 84. Pfizer, Inc Business Overview
Table 85. Pfizer, Inc Anti-inflammatory Therapeutics Product
Table 86. Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Pfizer, Inc Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Anti-inflammatory Therapeutics Product
Table 91. Novartis Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Novartis Recent Development
Table 93. Roche Company Details
Table 94. Roche Business Overview
Table 95. Roche Anti-inflammatory Therapeutics Product
Table 96. Roche Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Roche Recent Development
Table 98. Merck Company Details
Table 99. Merck Business Overview
Table 100. Merck Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Sanofi Company Details
Table 103. Sanofi Business Overview
Table 104. Sanofi Anti-inflammatory Therapeutics Product
Table 105. Sanofi Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Sanofi Recent Development
Table 107. GlaxoSmithKline Company Details
Table 108. GlaxoSmithKline Business Overview
Table 109. GlaxoSmithKline Anti-inflammatory Therapeutics Product
Table 110. GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million)
Table 111. GlaxoSmithKline Recent Development
Table 112. Sun Pharmaceutical Industries Ltd Company Details
Table 113. Sun Pharmaceutical Industries Ltd Business Overview
Table 114. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product
Table 115. Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million)
Table 116. Sun Pharmaceutical Industries Ltd Recent Development
Table 117. TEVA Company Details
Table 118. TEVA Business Overview
Table 119. TEVA Anti-inflammatory Therapeutics Product
Table 120. TEVA Revenue in Anti-inflammatory Therapeutics Business (2016-2021) & (US$ Million)
Table 121. TEVA Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-inflammatory Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Anti-inflammatory Biologics Features
Figure 3. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Features
Figure 4. Corticosteroids Features
Figure 5. Others Features
Figure 6. Global Anti-inflammatory Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Arthritis Case Studies
Figure 8. Respiratory Diseases Case Studies
Figure 9. Dermatology Case Studies
Figure 10. Gastroenterology Case Studies
Figure 11. Others Case Studies
Figure 12. Anti-inflammatory Therapeutics Report Years Considered
Figure 13. Global Anti-inflammatory Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Anti-inflammatory Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Anti-inflammatory Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Anti-inflammatory Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Anti-inflammatory Therapeutics Market Share by Players in 2020
Figure 18. Global Top Anti-inflammatory Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Anti-inflammatory Therapeutics Revenue in 2020
Figure 20. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Anti-inflammatory Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Anti-inflammatory Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Anti-inflammatory Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Anti-inflammatory Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Anti-inflammatory Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Anti-inflammatory Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Anti-inflammatory Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Anti-inflammatory Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Anti-inflammatory Therapeutics Market Share by Region (2016-2027)
Figure 42. China Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Anti-inflammatory Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Anti-inflammatory Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Anti-inflammatory Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Anti-inflammatory Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Anti-inflammatory Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Anti-inflammatory Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Anti-inflammatory Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AbbVie Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021)
Figure 63. Amgen Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021)
Figure 64. AstraZeneca PLC Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021)
Figure 65. Pfizer, Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021)
Figure 67. Roche Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021)
Figure 68. Merck Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021)
Figure 70. GlaxoSmithKline Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021)
Figure 71. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021)
Figure 72. TEVA Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed